Schroder Investment Management Group boosted its holdings in shares of Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 89.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 15,355 shares of the company's stock after purchasing an additional 7,266 shares during the quarter. Schroder Investment Management Group's holdings in Molina Healthcare were worth $4,469,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also made changes to their positions in MOH. Versant Capital Management Inc increased its stake in Molina Healthcare by 83.1% during the fourth quarter. Versant Capital Management Inc now owns 163 shares of the company's stock worth $47,000 after acquiring an additional 74 shares during the last quarter. Wingate Wealth Advisors Inc. purchased a new stake in Molina Healthcare during the 4th quarter worth about $52,000. EverSource Wealth Advisors LLC lifted its holdings in Molina Healthcare by 81.5% during the 4th quarter. EverSource Wealth Advisors LLC now owns 196 shares of the company's stock worth $57,000 after buying an additional 88 shares during the last quarter. Whittier Trust Co. of Nevada Inc. lifted its holdings in Molina Healthcare by 337.0% during the 4th quarter. Whittier Trust Co. of Nevada Inc. now owns 201 shares of the company's stock worth $58,000 after buying an additional 155 shares during the last quarter. Finally, Harvest Fund Management Co. Ltd lifted its holdings in shares of Molina Healthcare by 895.0% in the 4th quarter. Harvest Fund Management Co. Ltd now owns 199 shares of the company's stock valued at $58,000 after purchasing an additional 179 shares during the last quarter. Hedge funds and other institutional investors own 98.50% of the company's stock.
Insider Buying and Selling
In related news, Director Steven J. Orlando sold 1,000 shares of the stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $301.33, for a total value of $301,330.00. Following the completion of the transaction, the director now owns 17,375 shares of the company's stock, valued at $5,235,608.75. This represents a 5.44 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.10% of the stock is currently owned by corporate insiders.
Molina Healthcare Stock Performance
MOH stock traded up $1.39 during midday trading on Thursday, reaching $341.48. The company had a trading volume of 116,191 shares, compared to its average volume of 648,290. The company has a quick ratio of 1.62, a current ratio of 1.62 and a debt-to-equity ratio of 0.69. The stock has a 50 day moving average price of $309.45 and a 200 day moving average price of $308.20. The firm has a market capitalization of $18.68 billion, a PE ratio of 16.70, a P/E/G ratio of 1.06 and a beta of 0.70. Molina Healthcare, Inc. has a fifty-two week low of $262.32 and a fifty-two week high of $383.58.
Molina Healthcare (NYSE:MOH - Get Free Report) last announced its earnings results on Wednesday, February 5th. The company reported $5.05 EPS for the quarter, missing the consensus estimate of $5.74 by ($0.69). Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. Analysts anticipate that Molina Healthcare, Inc. will post 24.4 earnings per share for the current year.
Analyst Ratings Changes
Several brokerages recently issued reports on MOH. Mizuho boosted their price target on Molina Healthcare from $376.00 to $400.00 and gave the company an "outperform" rating in a research report on Wednesday. JPMorgan Chase & Co. reissued a "neutral" rating and set a $350.00 price target (down previously from $378.00) on shares of Molina Healthcare in a research note on Tuesday, December 17th. Guggenheim began coverage on Molina Healthcare in a research note on Wednesday. They issued a "neutral" rating on the stock. StockNews.com downgraded Molina Healthcare from a "buy" rating to a "hold" rating in a report on Thursday, April 3rd. Finally, Stephens reiterated an "equal weight" rating and issued a $345.00 price target on shares of Molina Healthcare in a report on Thursday, February 6th. Eight analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, Molina Healthcare has a consensus rating of "Moderate Buy" and a consensus price target of $350.75.
Check Out Our Latest Research Report on Molina Healthcare
Molina Healthcare Company Profile
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Featured Articles

Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.